Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Xianju Chen"'
Autor:
Jun Li, Qian Zhang, Yupeng Guan, Dingzhun Liao, Huikun Chen, Haiyun Xiong, Yiyu Sheng, Xianju Chen, Jun Pang
Publikováno v:
Cell Death and Disease, Vol 15, Iss 4, Pp 1-13 (2024)
Abstract Abnormal lipid metabolism and lipid accumulation are characteristic hallmarks of renal cell carcinoma (RCC). While there is prior evidence closely linking such lipid accumulation within RCC cells and consequent tumorigenesis, the mechanisms
Externí odkaz:
https://doaj.org/article/16ddc9689f514b54b17ee0e7fa0aa31e
Publikováno v:
BMC Public Health, Vol 23, Iss 1, Pp 1-14 (2023)
Abstract Background Association of cigarette smoking habits with the risk of prostate cancer is still a matter of debate. This systematic review and meta-analysis aimed to assess the association between cigarette smoking and prostate cancer risk. Met
Externí odkaz:
https://doaj.org/article/29783f426c53463da800f3b2ee6403de
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-9 (2022)
Abstract Background Androgen deprivation therapy (ADT) combined with docetaxel chemotherapy is the standard treatment for metastatic castration-resistant prostate cancer (mCRPC) patients. However, mCRPC patients are mainly frail elderly men, constant
Externí odkaz:
https://doaj.org/article/9c051b9daa4e45508ce01c68fd491580
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
BackgroundProstate cancer (PCa) is the second most common cancer among males in the world and the majority of patients will eventually progress to the metastatic phase. How to choose an effective way for the treatment of metastatic PCa, especially in
Externí odkaz:
https://doaj.org/article/a98ea879c71749a8b61f8c3c74941e2c
Autor:
Jin Li, Yiming Lai, Yi Cao, Tao Du, Lexiang Zeng, Ganping Wang, Xianju Chen, Jieqing Chen, Yongsheng Yu, Simin Zhang, Yiming Zhang, Hai Huang, Zhenghui Guo
Publikováno v:
Medical Oncology. 38
Autor:
Shoumin Bai, Zhenghui Guo, Xianju Chen, Shengmeng Peng, Tao Du, Hai Huang, Yiming Lai, Chunhao Lin, Wanhua Wu, Xiaoming Ma
Publikováno v:
Cancer Management and Research. 11:1517-1524
Background Biological mechanism of prostate cancer (PCa) recurrence and progress is complex but many of the key elements are not fully understood. Polo-like kinases (Plks) represent a family of highly conserved serine-threonine kinases that play esse
Publikováno v:
Frontiers in Oncology
Frontiers in Oncology, Vol 11 (2021)
Frontiers in Oncology, Vol 11 (2021)
BackgroundProstate cancer (PCa) is the second most common cancer among males in the world and the majority of patients will eventually progress to the metastatic phase. How to choose an effective way for the treatment of metastatic PCa, especially in
Autor:
Shoumin, Bai, Ting, Chen, Xiaoli, Yu, Ming, Luo, Xianju, Chen, Chunhao, Lin, Yiming, Lai, Hai, Huang
Publikováno v:
Oncology Reports. 44:2793-2794
Subsequently to the publication of the article, the authors have realized that some errors were contained therein that went uncorrected before the paper was sent to press. First, Fig. 4 contained a pair of data panels that had been misplaced: The LY2
Autor:
Leyuan Liu, Qi Li, Xianju Chen, Tao Du, Wenjiao Li, Xinxing Fan, Fei Yue, Guibin Xu, Yiming Lai, Kaiwen Li, Hai Huang
Publikováno v:
International Journal of Oncology. 50:640-648
Matrine is an alkaloid from Sophora flavescens that exhibits multiple protective effects on cancers. However, the molecular mechanisms of anti-metastatic effects of matrine on castration-resistant prostate cancer (CRPC) remain unknown. This study inv
Autor:
Xianju Chen, Leyuan Liu, Chunhao Lin, Wanhua Wu, Yiming Lai, Xiaoming Ma, Hai Huang, Qiong Wang, Dingjun Zhu, Zean Li, Tao Du
Publikováno v:
Oncology Letters.
Glioma tumor suppressor candidate region gene 1 (GLTSCR1) is associated with the progression of oligodendroglioma. However, there has been little study of GLTSCR1 in prostate cancer. In the present study, the association between the expression of GLT